COR
Cencora, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
COR
this stock
Cencora, Inc.
|
$57.69B | -12.1% | +9.3% | — | 3.2% |
|
MCK
Mckesson Corp
|
$94.52B | -4.1% | +3.1% | 20.5 | 3.7% |
|
CAH
Cardinal Health Inc
|
$56.23B | +16.8% | -1.9% | — | 3.8% |
|
HSIC
Henry Schein Inc
|
$9.85B | +14.4% | +5.9% | 26.1 | 6.7% |
|
EBOSY
EBOS Group Limited/ADR
|
$2.67B | -24.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| COR | +3.3% | +12.5% | -11.5% | +4.8% | -12.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +1.9% | +13.7% | -19.6% | +5.1% | -21.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.